Manipal Health Enterprises Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Manipal Health Enterprises Ltd filed with BSE on 27 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Manipal Health Enterprises reported Q1 FY27 revenue of INR3,091 crores, up over 38% year-on-year, with network EBITDA of INR749 crores, up over 26%. Growth was driven by patient volumes, with inpatient volumes up about 39% and OP volumes up 26%, along with continued ramp-up of Sahyadri Hospitals and recently commissioned greenfield facilities in Bangalore. Management also discussed the acquisition of Kinder Hospital in Whitefield, Bangalore, and provided updates on capex, leverage, and expansion plans across several cities.
1 statement from this call is not shown because its supporting quote could not be reproduced within our quoting limits. Nothing shown here is affected: every statement on this page carries its verified quote.
Numbers mentioned
Revenue: INR3,091 crores (Q1 FY27)
p. 3
“Our Q1 revenue of INR3,091 crores represents a growth of over 38% year-on-year.”
Dilip Jose, page 3 of the filed PDF · View the filing
Network EBITDA: INR749 crores (Q1 FY27)
p. 3
“Our network EBITDA was INR749 crores, a growth of over 26% over last year.”
Dilip Jose, page 3 of the filed PDF · View the filing
Operating margin excluding Sahyadri: 25% (Q1 FY27)
p. 3
“Our operating margin excluding Sahyadri was 25%, and at a network level that includes Sahyadri Hospitals, is at 24.2% for the quarter.”
Dilip Jose, page 3 of the filed PDF · View the filing
Inpatient volume growth: 39% (Q1 FY27 vs Q1 FY26)
p. 4
“Our inpatient volumes grew by about 39%, and OP volumes by 26% over Q1 of last year.”
Dilip Jose, page 4 of the filed PDF · View the filing
Average occupancy: 65% (Q1 FY27)
p. 4
“Average occupancy across our network was 65%, a 290 bps increase over Q1 of last year”
Dilip Jose, page 4 of the filed PDF · View the filing
ARPOB excluding Sahyadri: INR77,200 per day (Q1 FY27)
p. 4
“Excluding Sahyadri, our ARPOB is INR77,200 per day, a growth of about 9% over Q1 of last year.”
Dilip Jose, page 4 of the filed PDF · View the filing
Digital revenue: INR710 crores (Q1 FY27)
p. 4
“Our digital revenue grew significantly and contributed about INR710 crores during the quarter, representing about 23% of our overall revenue.”
Dilip Jose, page 4 of the filed PDF · View the filing
Sahyadri revenue: INR332 crores (Q1 FY27)
p. 4
“Sahyadri reported revenue of INR332 crores in Quarter 1, a growth of over 13% compared to last year.”
Dilip Jose, page 4 of the filed PDF · View the filing
Sahyadri EBITDA: INR58 crores (Q1 FY27)
p. 4
“EBITDA for the quarter was INR58 crores, a growth of about 19% year-on-year.”
Dilip Jose, page 4 of the filed PDF · View the filing
Sahyadri ARPOB: INR45,000 per day (Q1 FY27)
p. 4
“Operating performance also improved significantly: ARPOB grew by 15% to about INR45,000 a day, occupancy reached 63%”
Dilip Jose, page 4 of the filed PDF · View the filing
Sahyadri EBITDA margin: 17.5% (Q1 FY27)
p. 5
“We have reached EBITDA margins of almost 17.5% in the first quarter, which is a significant growth”
Dilip Jose, page 5 of the filed PDF · View the filing
Net debt to EBITDA: 2.8x (Q1 FY27)
p. 13
“As far as leverage is concerned, the net debt to EBITDA is around 2.8x.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Net debt to EBITDA post debt repayment: 0.9x (Q1 FY27 level)
p. 13
“Once we repay this debt, which we will do in Quarter 2, since the trigger has already been initiated post receiving the IPO funds, our net debt to EBITDA will go down to 0.9x at quarter 1 level.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Capex spent: INR900 crores (Q1 FY27)
p. 13
“Almost INR900 crores has been spent in Quarter 1, so we're trying to front-end a lot of capex”
Sameer Agarwal, page 13 of the filed PDF · View the filing
AMRI growth: 17% (Q1 FY27 vs Q1 FY26)
p. 15
“AMRI, actually this quarter has grown 17% over last year same quarter, and Medica has grown 15%.”
Sameer Agarwal, page 15 of the filed PDF · View the filing
Greenfield EBITDA margin: 13% (Q1 FY27)
p. 12
“in Q1, we have 13% EBITDA margin from the greenfields, way ahead of any plans that we had.”
Dilip Jose, page 12 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Capex over next 3-4 years — INR4,000 crores · next 3-4 years
stated firmly by Sameer Agarwal
p. 13
“We have in the next 3-4 years as we add the 3,000 beds, we will spend around INR4,000 crores of capex.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Capex for current year — INR2,000 crores · FY27
stated firmly by Sameer Agarwal
p. 13
“As far as the capex for the current year is concerned, I think so current year, we will end up spending almost INR2,000 crores of capex because of the greenfields and brownfields that are coming up.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Leverage target — 1.5 to 2x net debt to EBITDA
stated as an aspiration by Sameer Agarwal
p. 13
“I think leverage of industry averages currently are around 1.5 to 2. We are fairly comfortable operating at that level.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Raipur hospital commissioning — Q4 FY27
stated firmly by Karthik Rajagopal
p. 10
“And we're expecting Raipur to get commissioned in, the Q4 of FY27.”
Karthik Rajagopal, page 10 of the filed PDF · View the filing
Ahilya Nagar bed addition — about 80 beds · FY28
stated conditionally by Karthik Rajagopal
p. 10
“And Ahilya Nagar in FY28 could add about close to 80 beds.”
Karthik Rajagopal, page 10 of the filed PDF · View the filing
Sahyadri margin convergence — 18-month integration period
stated as an aspiration by Dilip Jose
p. 5
“The integration process, you know, the way we have planned is over an 18-month kind of a period.”
Dilip Jose, page 5 of the filed PDF · View the filing
Sahyadri margin push toward portfolio level — next few quarters
stated as an aspiration by Dilip Jose
p. 7
“At Sahyadri, like Karthik mentioned earlier, as those initiatives take shape over the next few quarters, we expect to push up Sahyadri closer to where the portfolio is.”
Dilip Jose, page 7 of the filed PDF · View the filing
Kinder Hospital transfer completion — next 60 days
stated conditionally by Dilip Jose
p. 15
“Like Sameer said, after CPs are completed, we expect in the next 60 days the transfer to fully take place, and then take up remodeling that asset”
Dilip Jose, page 15 of the filed PDF · View the filing
Kinder Hospital remodeling timeline — 6-7 months
stated firmly by Dilip Jose
p. 14
“I think we will, over the next 6-7 months, remodel that hospital to multispecialty, and then we would really take it to its potential”
Dilip Jose, page 14 of the filed PDF · View the filing
Geographic expansion — Kerala, NCR, Hyderabad
stated as an aspiration by Dilip Jose
p. 18
“We have, you know, keen interest to expand to Kerala, you know, as and when an opportunity arises. We would be keen to further expand our presence in NCR. We would want to look at Hyderabad.”
Dilip Jose, page 18 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management described an 18-month integration playbook focused on regional HR structure, clinician interoperability, branding, digital penetration, and service strategy.
Answered by Karthik Rajagopal
Asked by Damayanti Kerai: What is management's focus for improving Sahyadri's profitability and closing the margin gap with the corporate average, and what is the expected turnaround time?
p. 6
“The entire piece is we follow a certain playbook when it comes to looking at acquisitions, you know, and how we look at the integration. So the whole process takes about 16 to 18 months.”
Karthik Rajagopal, page 6 of the filed PDF · View the filing
Management attributed the margin dip to a one-off gain last year and greenfield ramp-up costs, and said several hospitals in the portfolio operate above 30% margin, indicating room for improvement without giving a specific target.
Answered by Dilip Jose
Asked by Neha Manpuria: How should ex-Sahyadri margins be viewed over an 18-24 month horizon and where is there scope for improvement?
p. 8
“We have hospitals at 30% margin, in excess of 30% margin, several hospitals greater than 30- 32% margin. So, we would work towards pushing up our portfolio of entire network to further improve to those levels.”
Dilip Jose, page 8 of the filed PDF · View the filing
Management pointed to expansions underway at multiple Sahyadri locations and reiterated the same playbook used in past turnarounds without specifying numeric targets.
Answered by Dilip Jose
Asked by Bansi Desai: What is the medium- to long-term build-out plan and margin aspiration for Sahyadri given historical post-acquisition investment patterns?
p. 9
“Deccan Gymkhana is undergoing an expansion. An entire tower is getting added. Hadapsar is adding beds.”
Dilip Jose, page 9 of the filed PDF · View the filing
Management said the doctor cost impact of the two Bangalore greenfields was about 0.5% of network margin, with the remainder from a one-off gain last year and slower scheme collections.
Answered by Dilip Jose
Asked by Shyam Srinivasan: Can management quantify the greenfield losses dragging on ex-Sahyadri margins?
p. 11
“So the doctor cost element of that is about 0.5% for the network. That's the impact that we have.”
Dilip Jose, page 11 of the filed PDF · View the filing
Management said net debt to EBITDA would fall to 0.9x after debt repayment and that they are comfortable operating around industry average leverage of 1.5-2x, with capex of about INR4,000 crores planned over the next 3-4 years.
Answered by Sameer Agarwal
Asked by Aman Goyal: What optimal leverage level is management comfortable with post-IPO debt repayment, and what is the capex guidance for the next 2-3 years?
p. 13
“Once we repay this debt, which we will do in Quarter 2, since the trigger has already been initiated post receiving the IPO funds, our net debt to EBITDA will go down to 0.9x at quarter 1 level.”
Sameer Agarwal, page 13 of the filed PDF · View the filing
Management said Kinder's current revenue and margin profile is not relevant to the rationale for the acquisition, which is about capacity addition in a high-growth micro-market.
Answered by Dilip Jose
Asked by Bala Murali Krishna: What is the average EBITDA margin of the Kinder acquisition?
p. 14
“It is really not to build on women and children, capability that Kinder has.”
Dilip Jose, page 14 of the filed PDF · View the filing
Management said AMRI grew 17% and Medica grew 15% year-on-year, with cash and TPA business growing faster than the overall region due to a slowdown in the government scheme mix.
Answered by Sameer Agarwal
Asked by Alankar Garude: How is AMRI and Medica performing, and when will their margins reach network-level margins?
p. 15
“AMRI, actually this quarter has grown 17% over last year same quarter, and Medica has grown 15%.”
Sameer Agarwal, page 15 of the filed PDF · View the filing
Management said there are no such plans and the company intends to remain focused on tertiary and quaternary hospital care.
Answered by Dilip Jose
Asked by Karan Vora: Are there plans to bring Manipal Group's medical colleges into the listed entity given regulatory changes allowing for-profit medical colleges?
p. 17
“No, Karan. We have no such plans.”
Dilip Jose, page 17 of the filed PDF · View the filing
Risks flagged
Slower collections from scheme patients affecting margins in the quarter
p. 11
“in Q1, some of the collection, particularly the scheme patients collection has been a little slow, like the whole sector has been talking about.”
Dilip Jose, page 11 of the filed PDF · View the filing
Transition in government health scheme mix in East region creating uncertainty
p. 15
“We already started seeing the slowdown of the government mix because the scheme will get maybe rechristened from the current scheme to the national scheme.”
Sameer Agarwal, page 15 of the filed PDF · View the filing
Greenfield hospitals still ramping up and diluting composite margin
p. 7
“greenfields which are up in Bangalore, they are still ramping up. Although ahead of our plan, greenfields are ramping up. That brings down our composite margin a tad.”
Dilip Jose, page 7 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.